Human polyomavirus-7-associated eruption successfully treated with acitretin

Am J Transplant. 2018 May;18(5):1278-1284. doi: 10.1111/ajt.14634. Epub 2018 Jan 21.

Abstract

Advances in molecular technologies have led to the discovery of several novel human polyomaviruses (HPyVs), including human polyomavirus-7 (HPyV-7). Although low levels of HPyV-7 are shed from apparently normal skin, recent reports have described clinically significant cutaneous infection in immunocompromised patients that manifests as generalized pruritic plaques. The pruritus can be severe, and treatment options have not been described. Herein we report HPyV-7 cutaneous infection in a heart transplant patient who experienced temporary improvement with intravenous cidofovir, and complete remission with acitretin. We report a case of HPyV-7 cutaneous infection demonstrating a good response to treatment.

Keywords: biopsy; clinical research/practice; complication: infectious; dermatology; heart (allograft) function/dysfunction; immunosuppressant - mechanistic target of rapamycin (mTOR); infection and infectious agents - viral: BK/JC/polyoma; infectious disease.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / therapeutic use*
  • Heart Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host / immunology*
  • Keratolytic Agents / therapeutic use
  • Male
  • Middle Aged
  • Polyomavirus / immunology*
  • Polyomavirus Infections / complications*
  • Polyomavirus Infections / immunology
  • Polyomavirus Infections / virology
  • Prognosis
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Pruritus / pathology
  • Tumor Virus Infections / complications*
  • Tumor Virus Infections / immunology
  • Tumor Virus Infections / virology

Substances

  • Keratolytic Agents
  • Acitretin